You are here: vision-research.eu » People » Research Groups » United Kingdom » Coupland, Sarah

Liverpool Ocular Oncology Research Group (LOORG)

The Liverpool Ocular Oncology Research Group’s (LOORG’s) mission is to conduct high quality basic, translational and clinical research into the pathogenesis and treatment of adult ocular tumours that will improve patient care and survival. The Liverpool Ocular Oncology Research Group (LOORG) was established by Professor Sarah Coupland and Professor Bertil Damato in 2006. Prof. Coupland has since lead the basic science and translational research portfolio, in addition to being a Consultant Pathologist at the Royal Liverpool University Hospital.

A major strength of the LOORG is the close collaboration between ocular oncology clinicians (Lead, Professor Heimann), pathologists and basic scientists (Dr Sarah Lake and Dr Helen Kalirai) which ensures that the research we conduct addresses the key questions that will bring about improved survival and quality of life for ocular oncology patients.

Group Leader

Sarah E. Coupland
[more information]

Contact

University of Liverpool

Molecular and Clinical Cancer Medicine
Institute of Translational Medicine
6th Floor, Duncan Building
L69 3GA Liverpool
United Kingdom

Phone: +44(0)151 706 4494
Fax: +44(0)151 706 5826

E-mail:
s.e.coupland[at]liverpool.ac.uk

Website:
www.loorg.org

Current Research Projects

  • Project 1:
    Identification of regulators of metastasis in uveal melanoma
  • Project 2:
    Proteomic discovery of serum biomarkers in metastatic uveal melanoma
  • Project 3:
    Estimating survival prognosis after treatment of choroidal melanoma
  • Project 4:
    Gross chromosomal abnormalities in iris melanoma
  • Project 5:
    Molecular characteristics of metastatic liver lesions in uveal melanoma: the search for therapeutic targets

Research Groups

People

Related Research Groups

clinical laboratory testing
Oops, an error occurred! Code: 202103070109409596f616
conjunctiva
Oops, an error occurred! Code: 20210307010940f0509dd9
disease gene mapping
Oops, an error occurred! Code: 20210307010940e41d0837
gene/expression
Oops, an error occurred! Code: 202103070109400941e09e
gene microarray
Oops, an error occurred! Code: 2021030701094090cada98
genetics
Oops, an error occurred! Code: 202103070109407ebb7803
immunohistochemistry
Oops, an error occurred! Code: 202103070109405f89aca0
iris
Oops, an error occurred! Code: 20210307010940d66480e4
melanoma
Oops, an error occurred! Code: 20210307010940bcf1f974
oncology
Oops, an error occurred! Code: 2021030701094085c87ff2
pathology: experimental
Oops, an error occurred! Code: 20210307010940c15a4e96
pathology: human
Oops, an error occurred! Code: 2021030701094075ecceea
pathology techniques
Oops, an error occurred! Code: 20210307010940f09bbb05
tumors
Oops, an error occurred! Code: 202103070109400c5ed099
uvea
Oops, an error occurred! Code: 202103070109400d05ed6e
vision and action
Oops, an error occurred! Code: 20210307010940d9035aa1
visual acuity
Oops, an error occurred! Code: 20210307010940b71fb1e8
uveal melanoma
Oops, an error occurred! Code: 20210307010940c0466fc3
conjunctival melanoma
Oops, an error occurred! Code: 202103070109400597fb3f
intraocular and ocular adnexal lymphomas
Oops, an error occurred! Code: 202103070109405c80f37c
pathology
Oops, an error occurred! Code: 2021030701094068be998b
translational studies
Oops, an error occurred! Code: 20210307010940094ea7e2